乳腺癌初次肿块切除术后再次手术趋势:应对手术治疗中的过度治疗
基于佐治亚州和加州洛杉矶县SEER登记的人群队列研究,分析2013至2015年I-II期乳腺癌患者初次肿块切除术后再次手术率及最终手术方式的变化,并调查外科医生对「肿瘤无墨染」切缘的认可度。结果显示最终肿块切除术率增加13%,单侧和双侧乳房切除术减少(P=0.002),初次肿块切除术后再次手术下降16%(P<0.001)。
要点
- 2013至2015年最终肿块切除术率增加13%,单侧和双侧乳房切除术减少(P=0.002)。
- 初次肿块切除术后再次手术下降16%(P<0.001)。
- 年治疗超过50例乳腺癌的外科医生更可能认可「肿瘤无墨染」切缘(85% vs 55%,P<0.001)。
核心结论
- 初次肿块切除术后再次手术从2013至2015年明显下降,与认可最小阴性切缘的临床指南传播同时发生。
- 作者认为,外科医生主导的应对潜在过度治疗的举措可减轻癌症患者的手术治疗负担。
研究设计与样本
- 基于人群的队列调查研究,纳入2013至2015年在佐治亚州和加州洛杉矶县SEER登记诊断的7303例20至79岁I-II期乳腺癌合格女性。
- 5080例(70%)返回调查,排除双侧病变、分期或治疗数据缺失及导管原位癌后,分析样本为3729例患者,其中98%确定了主治外科医生。
- 2015年4月至2016年5月调查488名外科医生关于肿块切除切缘,342名(70%)完整回复。
- 审查所有接受第二次手术患者的病理报告及接受1次手术患者的30%样本,采用多项回归模型分析时间趋势。
主要发现
- 3729例分析样本中初次肿块切除术率为67%,研究期间未变化。
- 2013至2015年最终肿块切除术率增加13%,单侧和双侧乳房切除术减少(P=0.002)。
- 初次肿块切除术后再次手术下降16%(P<0.001)。
- 病理审查显示治疗日期与阳性切缘无显著关联。
- 342名回复的外科医生中,69%认可「肿瘤无墨染」切缘以避免雌激素受体阳性孕激素受体阳性癌症再次切除,63%认可用于雌激素受体阴性孕激素受体阴性癌症。
关键数值与推荐
- 2014年共识声明认可「肿瘤无墨染」切缘。
- 外科医生认可「肿瘤无墨染」切缘以避免再次切除:雌激素受体阳性孕激素受体阳性癌症69%,雌激素受体阴性孕激素受体阴性癌症63%。
- 年治疗超过50例乳腺癌的外科医生中85%(n=105)报告该切缘充足,年治疗20例或以下者中55%(n=131)(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Surgery after initial lumpectomy to obtain more widely clear margins is common and may lead to mastectomy. OBJECTIVE: To describe surgeons' approach to surgical margins for invasive breast cancer, and changes in postlumpectomy surgery rates, and final surgical treatment following a 2014 consensus statement endorsing a margin of "no ink on tumor." DESIGN, SETTING, AND PARTICIPANTS: This was a population-based cohort survey study of 7303 eligible women ages 20 to 79 years with stage I and II breast cancer diagnosed in 2013 to 2015 and identified from the Georgia and Los Angeles County, California, Surveillance, Epidemiology, and End Results registries. A total of 5080 (70%) returned a survey. Those with bilateral disease, missing stage or treatment data, and with ductal carcinoma in situ were excluded, leaving 3729 patients in the analytic sample; 98% of these identified their attending surgeon. Between April 2015 and May 2016, 488 surgeons were surveyed regarding lumpectomy margins; 342 (70%) responded completely. Pathology reports of all patients having a second surgery and a 30% sample of those with 1 surgery were reviewed. Time trends were analyzed with multinomial regression models. MAIN OUTCOMES AND MEASURES: Rates of final surgical procedure (lumpectomy, unilateral mastectomy, bilateral mastectomy) and rates of additional surgery after initial lumpectomy over time, and surgeon attitudes toward an adequate lumpectomy margin. RESULTS: The 67% rate of initial lumpectomy in the 3729 patient analytic sample was unchanged during the study. The rate of final lumpectomy increased by 13% from 2013 to 2015, accompanied by a decrease in unilateral and bilateral mastectomy (P = .002). Surgery after initial lumpectomy declined by 16% (P < .001). Pathology review documented no significant association between date of treatment and positive margins. Of 342 responding surgeons, 69% endorsed a margin of no ink on tumor to avoid reexcision in estrogen receptor-positive progesterone receptor-positive cancer and 63% for estrogen receptor-negative progesterone- receptor-negative cancer. Surgeons treating more than 50 breast cancers annually were significantly more likely to report this margin as adequate (85%; n = 105) compared with those treating 20 cases or fewer (55%; n = 131) (P < .001). CONCLUSIONS AND RELEVANCE: Additional surgery after initial lumpectomy decreased markedly from 2013 to 2015 concomitant with dissemination of clinical guidelines endorsing a minimal negative margin. These findings suggest that surgeon-led initiatives to address potential overtreatment can reduce the burden of surgical management in patients with cancer.
引用
- Morrow M, Abrahamse P, Hofer TP, et al. Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management. JAMA Oncol. 2017. PMID: 28586788. doi:10.1001/jamaoncol.2017.0774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。